WSJ Highlights More 'Smoke' at Valeant Pharma (VRX) Ahead of Conference Call

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. NVDA
2. SPY
3. EYPT
4. CRWV
5. AMZN
6. META
7. TSLA
8. IRON
9. SPCX
10. STLD

Go back to WSJ Highlights More 'Smoke' at Valeant Pharma (VRX) Ahead of Conference Call

Valeant Pharmaceuticals Confirms Appropriateness Of Accounting, Appoints Ad Hoc Board Committee To Review Philidor

October 26, 2015 6:15 AM EDT

VALEANT TO HOLD INVESTOR CONFERENCE CALL AT 8:00 AM ET

LAVAL, Quebec, Oct. 26, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that its Audit and Risk Committee and the full Board of Directors have reviewed the company's accounting for its Philidor arrangement and have confirmed the appropriateness of the company's related revenue recognition and accounting treatment.

Based on its review conducted to date, Valeant also believes that the company is in compliance with applicable law. In... More